Actualidad
)
23 September 2019
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
VIVEbiotech has carried out a capital increase of 3.5 million euros to finance its strategic plan, which highlights the construction of three new cleanrooms and the...
Read more)
6 September 2019
The Minister of Health visits VIVEbiotech
The Minister of Health, María Luisa Carcedo, has visited VIVEbiotech.
Read more)
20 June 2019
VIVEbiotech joins the #juntosporedaravet campaign organized by the Apoyodravet association
VIVEbiotech has joined the #juntosporeldravet campaign organized by the Apoyodravet association this week, coinciding with the International Dravet Syndrome Awareness Day. As they told us...
Read more)
13 June 2019
VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office
VIVEbiotech, a company specialized in the production of lentiviral vectors for their use in gene therapy, has received notification of the patent grant for the...
Read more)
24 May 2019
VIVEbiotech participa en el World Advanced Therapies and Regenerative Medicine Congress en Londres
El World Advanced Therapies and Regenerative Congress tuvo lugar en el Business Design Centre de Londres del 15 al 17 de mayo.
Read more)
14 May 2019
VIVEbiotech participates in two conferences last April
VIVEbiotech has participated in two international conferences this past April.
Read more)
29 March 2019
VIVEbiotech receives the visit of a Colombian business delegation
Fourteen Colombian businessmen belonging to companies strongly implanted in Colombia visited VIVEbiotech on March 26.
Read more)
20 March 2019
VIVEbiotech participates in the FP-PARKE Forum
VIVEbiotech participated in the FP-PARKE Forum that took place last Tuesday, March 12, at the Gipuzkoa Science and Technology Park.
Read more)
20 February 2019
The President of the Basque Government meets with the Board of Directors of VIVEbiotech
The Lehendakari Iñigo Urkullu, President of the Basque Government, received the Board of Directors of VIVEbiotech yesterday in Lehendakaritza.
Read more)
5 February 2019
Noticias de Álava interviews the CEO of VIVEbiotech, Dr. Gurutz Linazasoro
Noticias de Álava interviews the CEO of VIVEbiotech, Dr. Gurutz Linazasoro, after his participation in the Regenerative Medicine and Advanced Therapies workshop
Read moreDestacadas
)
)
4 June 2021
VIVEbiotech launches lentiviral vector manufacturing plant for cell and gene therapy sector
)
26 February 2021
26 February 2021
)